Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

3-12-2015

Modulation of type II TGF-β
TGF- receptor degradation by integrinlinked kinase
Linda Vi
Western University

Stellar Boo
Western University

Samar Sayedyahossein
Western University

Randeep K. Singh
Western University

Sarah Mclean
Western University

See next page for additional authors

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub
Part of the Pediatrics Commons

Citation of this paper:
Vi, Linda; Boo, Stellar; Sayedyahossein, Samar; Singh, Randeep K.; Mclean, Sarah; Di Guglielmo, Gianni M.;
and Dagnino, Lina, "Modulation of type II TGF-β receptor degradation by integrin-linked kinase" (2015).
Paediatrics Publications. 1040.
https://ir.lib.uwo.ca/paedpub/1040

Authors
Linda Vi, Stellar Boo, Samar Sayedyahossein, Randeep K. Singh, Sarah Mclean, Gianni M. Di Guglielmo,
and Lina Dagnino

This article is available at Scholarship@Western: https://ir.lib.uwo.ca/paedpub/1040

ORIGINAL ARTICLE

Modulation of Type II TGF-b Receptor Degradation by
Integrin-Linked Kinase
Linda Vi1,2,3, Stellar Boo1,2,3, Samar Sayedyahossein1,2, Randeep K. Singh1,2, Sarah McLean1,
Gianni M. Di Guglielmo1 and Lina Dagnino1,2
Cutaneous responses to injury, infection, and tumor formation involve the activation of resident dermal
fibroblasts and subsequent transition to myofibroblasts. The key for induction of myofibroblast differentiation is
the activation of transforming growth factor-b (TGF-b) receptors and stimulation of integrins and their associated
proteins, including integrin-linked kinase (ILK). Cross-talk processes between TGF-b and ILK are crucial for
myofibroblast formation, as ILK-deficient dermal fibroblasts exhibit impaired responses to TGF-b receptor
stimulation. We now show that ILK associates with type II TGF-b receptors (TbRII) in ligand- and receptor kinase
activity–independent manners. In cells with targeted Ilk gene inactivation, cellular levels of TbRII are decreased,
through mechanisms that involve enhanced ubiquitination and proteasomal degradation. Partitioning of TGF-b
receptors into membrane has been linked to proteasome-dependent receptor degradation. We found that
interfering with membrane raft formation in ILK-deficient cells restored TbRII levels and signaling. These
observations support a model whereby ILK functions in fibroblasts to direct TbRII away from degradative
pathways during their differentiation into myofibroblasts.
Journal of Investigative Dermatology (2015) 135, 885–894; doi:10.1038/jid.2014.427; published online 13 November 2014

INTRODUCTION
Fibroblasts are a heterogeneous population of highly plastic
mesenchymal cells found in close association with the extracellular matrix of all tissues (reviewed in McAnulty, 2007).
They function to produce and maintain extracellular matrix
through the expression of collagens, fibronectin, and enzymes
that regulate the extracellular degradation of these proteins.
Reciprocally, fibroblast behavior is modulated by multiple
signals present in their local environment.
Fibroblasts have key roles in tissue responses to many types
of disruption, including injury, infections, and the presence of
tumors. In response to these alterations, cytokines and other
factors produced at the affected site activate resident fibroblasts, inducing their transition into myofibroblasts. The latter
are characterized by the expression of a-smooth muscle actin
(a-SMA), the capacity to generate contractile forces, and the
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ability to synthesize extracellular matrix components (Hinz
et al., 2007). On tissue injury, fibroblast differentiation occurs
in response to transforming growth factor-b (TGF-b) and
increased extracellular tension (Hinz et al., 2007). Significantly, the myofibroblast phenotype is recapitulated in cancerassociated fibroblasts (CAFs), which arise from mesenchymal
cells neighboring epithelial tumors in the absence of mechanical
tissue disruption (Polanska and Orimo, 2013). Reciprocal stimulation of CAFs and carcinoma cells results in increased tumor
cell proliferation, survival, invasion, and metastasis. Importantly,
tumor-derived cytokines, including TGF-b1, are key stimuli for
CAF formation (Kojima et al., 2010).
TGF-b receptor signaling pathways are modulated by a
variety of mechanisms in fibroblasts, including cross talk with
integrins and their effector proteins (Boo and Dagnino, 2013).
Integrins transduce signals from the extracellular matrix by
interacting with downstream effectors, such as integrin-linked
kinase (ILK; Dagnino, 2011). ILK is a scaffold protein that has
multiple important roles in the skin, including hair follicle
formation and regeneration after wounding (Lorenz et al.,
2007; Nakrieko et al., 2008b, 2011; Judah et al., 2012; Ho
and Dagnino, 2012b; Rudkouskaya et al., 2013). In dermal
fibroblasts, Ilk gene inactivation causes impaired cutaneous
regeneration, and is associated with attenuated responses to
TGF-b stimulation, through poorly understood mechanisms
(Blumbach et al., 2010; Vi et al., 2011). We now show that
ILK forms complexes with type II TGF-b receptor (TbRII) in
dermal fibroblasts and that, in its absence, TbRII signaling
decreases because of increased proteasomal degradation of
this receptor.
www.jidonline.org
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RESULTS
Formation of TbRII complexes containing ILK

Inactivation of the Ilk gene in primary mouse dermal fibroblasts results in attenuated phosphorylation of SMAD proteins
and a-SMA expression in response to TGF-b1 (Vi et al., 2011).
To address the mechanisms involved in ILK modulation of
TGF-b signaling, we first examined whether ILK associates
with receptors for this growth factor. Fibroblasts were
incubated in serum-free medium for 4 hours, followed by
culture in the presence or absence of TGF-b1 (10 ng ml  1) for
1 hour. Under these conditions, phosphorylated SMAD 2 was
detected only in TGF-b1-treated cells (Figure 1a). We
observed the presence of TbRII in ILK immunoprecipitates
from these cultures, irrespective of whether or not cells were
treated with TGF-b1 (Figure 1a). Reciprocally, we observed
the presence of ILK in TbRII immunoprecipitates from cells
incubated with or without TGF-b1 (Figure 1a). We next
expressed hemagglutinin (HA)-tagged TbRII together with
V5-tagged ILK in IMDF cells, a line of spontaneously immortalized dermal fibroblasts we previously generated
(Apostolova et al., 2002). Unlike primary mouse dermal
fibroblasts, IMDF cells transfect with very high efficiency,
allowing analyses using exogenous proteins. We found the
presence of V5-tagged ILK in HA immunecomplexes and,
conversely, HA-TbRII in V5 immunoprecipitates (Figure 1b).
We also observed that the endogenous mouse TbRII exhibited
slightly lower mobility on denaturing gels compared with the
exogenously expressed human orthologue (Figure 1a and b).
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TbRII was predominantly localized to intracellular vesicles
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stimulated with TGF-b1 for 1 hour, formation of cell protrusions was frequently observed, and colocalization of TbRII and
ILK immunoreactivity was readily detected (Figure 1d). Thus,
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Figure 1. ILK association with type II TGF-b receptors. (a) Ilkf/f fibroblasts were cultured in serum-free medium for 4 hours, followed by a 1-hour incubation period
with or without TGF-b1 (10 ng ml  1). Cell lysates were prepared and subjected to immunoprecipitation with antibodies against TbRII or ILK. Immunecomplexes
were resolved by denaturing gel electrophoresis and transferred to membranes, which were probed with the indicated antibodies. (b) Forty hours after transfection
with vectors encoding V5-ILK and/or HA-TbRII, IMDF cells were cultured as described in panel a. Lysates were then prepared and immunoprecipitated with antiHA or anti-V5 antibodies. The immunoblot results are representative of six experiments, using IMDF or four different dermal fibroblast isolates. IMDF (c) or Rat-2
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Figure 2. Protein regions involved in the interactions between ILK and TbRII. (a, b) IMDF cells were transfected with vectors encoding the indicated V5-ILK and/
or HA-TbRII proteins and cultured for 40 hours. Cell lysates were immunoprecipitated with anti-HA antibodies and analyzed by immunoblot with anti-V5
antibodies. (c) Primary dermal fibroblasts were cultured in serum-free HyQ DMEM-RS medium for 3.5 hours. At this time, SB431542 (10 nM) or dimethylsulfoxide
(vehicle) was added, and incubation proceeded for 30 minutes, followed by addition of TGF-b1 (10 ng ml  1, final) to the culture medium, and incubation for one
additional hour. Cell lysates were immunoprecipitated with anti-ILK antibodies or unrelated IgG, followed by immunoblot analysis with anti-TbRII antibodies.
P-SMAD 2, phospho-SMAD 2. The results are representative of five experiments, using IMDF or four different dermal fibroblast isolates. HA, hyaluronic acid; ILK,
integrin-linked kinase; TGF-b1, transforming growth factor-b1; TbRII, type II TGF-b receptor; Wt, wild type.

proteins. ILK E359K exhibits severely impaired scaffolding
properties and cannot bind paxillin and parvins (Nikolopoulos
and Turner, 2001, 2002). ILK E359K was found in HA-TbRII
immunoprecipitates, indicating that binding of ILK to TbRII
does not involve association with paxillin or parvins, or
regions in ILK necessary for its interaction with these
proteins (Figure 2a). A deletion mutant with only the C-terminal pseudokinase domain (ILK 191–452), which does not
localize to focal adhesions (Yamaji et al., 2001), was similarly
able to associate with TbRII. Of note, ILK mutants consisting of
the N-terminal 192 or 250 amino acid residues were also
found in TbRII immunecomplexes (Figure 2a). The ability of
both the N- and C-terminal halves of ILK to associate with
TbRII is reminiscent of its interaction with ELMO2, another
scaffold protein involved in cell migration (Ho et al., 2009).
To further confirm the specificity of these interactions,
we conducted reciprocal immunoprecipitation experiments.
We isolated V5 immunecomplexes from cells exogenously
expressing V5-tagged wild-type ILK, ILK 1-192, or ILK 191–
452 and found the presence of HA-tagged TbRII (Supplementary Figure S1 online).
We next examined the role of the TbRII extracellular
domain for its association with ILK. The latter was readily
detected in immunecomplexes that contained HA-tagged
TbRII 155–567 (Figure 2b), a mutant that contains only the
transmembrane and cytoplasmic domains and which localizes
to the plasma membrane (Luga et al., 2009). The ability of ILK
to associate with this TbRII mutant that lacks the extracellular
domain also implies that ligand binding to the receptor is not
required for its interaction with ILK.

Interactions between ILK and TbRII are independent of receptor
kinase activity

TbRII is a constitutively active serine–threonine kinase, which
does not require ligand binding for enzymatic activity and
autophosphorylation (Luo and Lodish, 1997). To determine
whether TbRII activity is necessary for its interaction with ILK,
we co-expressed V5-ILK and HA-TbRII K277R. This mutant
retains the ability to bind TGF-b and TbRI but lacks kinase
activity (Wrana et al., 1992). We readily detected ILK in TbRII
K277R immunecomplexes (Figure 2b), indicating that TbRII
does not require serine–theronine kinase activity to associate
with ILK.
Cellular TbRI and TbRII form homo- and hetero-oligomers.
TbRI/TbRII complex formation does not require TGF-b
(Rechtman et al., 2009), but this growth factor is necessary
for stimulation of TbRI kinase activity and phosphorylation of
downstream effectors, including SMAD 2 and 3 (Massague,
2012). Therefore, we next examined whether TbRII is present
in ILK immunecomplexes from fibroblasts treated with
SB431542, a highly selective TbRI inhibitor (Inman et al.,
2002). We found no detectable differences in the levels of
TbRII associated with ILK in cells incubated with or without
this inhibitor (Figure 2c). Thus, active TbR heteromeric
complexes are not necessary for the association between ILK
and TbRII to occur.
Alterations in TbRII abundance in ILK-deficient fibroblasts

Given that responses to TGF-b1 stimulation are attenuated in
ILK-deficient dermal fibroblasts (Vi et al., 2011), we investigated whether the loss of ILK expression alters TbRII
www.jidonline.org
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Figure 3. Effect of Ilk gene inactivation on TbRII abundance and signaling.
(a) Ilkf/f fibroblasts were infected with Ad-bgal or Ad-Cre, and 96 hours later
cell lysates were prepared and analyzed by immunoblot with antibodies
against TbRII or TbRI. (b) Cells were transduced as in a and 96 hours after
infection were incubated in serum-free medium for 4 hours and then in
medium with or without TGF-b1 for 1 hour. Lysates were prepared and
immunoprecipitated with anti-TbRI antibodies. The immunecomplexes were
analyzed by immunoblot, using anti-TbRII antibodies. The asterisk indicates a
nonspecific band. The results are representative of five experiments, using three
different dermal fibroblast isolates. ILK, integrin-linked kinase; TGF-b1,
transforming growth factor-b1; TbRII, type II TGF-b receptor.

abundance. We isolated fibroblasts from mice containing
floxed Ilk alleles (Terpstra et al., 2003) (hereafter termed Ilkf/f
mice) and transduced them with adenoviruses encoding Cre
recombinase (Ad-Cre) or control b-galactosidase (Ad-bgal).
Expression of Ad-Cre in these cells results in a X90%
reduction in ILK 72–96 hours following transduction
(Vi et al., 2011). Under these conditions, we observed
substantially depleted levels of TbRII in ILK-deficient cells
(Figure 3a). We found no significant differences in the
abundance of TbRI irrespective of whether or not ILK was
expressed (Figure 3a), indicating that ILK selectively modulates
TbRII abundance in primary mouse dermal fibroblasts.
To determine the consequences of reduced TbRII levels on
the abundance of TbRI/TbRII signaling receptor complexes,
we isolated TbRI immunecomplexes from cells treated with or
without TGF-b1. We observed increased levels of TbRII in
TbRI immunoprecipitates in lysates from ILK-expressing cells
treated with TGF-b1 (Figure 3b). In contrast, TbRII was barely
detectable in TbRI immunecomplexes from ILK-deficient cells
in the presence or absence of TGF-b1 (Figure 3b), indicating
that decreased TbRII levels in ILK-deficient fibroblasts are
accompanied by decreased abundance of heteromeric TbRI/
TbRII complexes.
We next measured responses to TGF-b1 in ILK-deficient
cells in which human ILK was exogenously expressed. To this
end, we transduced Ilkf/f fibroblasts with Ad-bgal or Ad-Cre,
followed 48 hours later by a second transduction step with
either Ad-bgal or with adenovirus encoding human ILK (AdILK; Vespa et al., 2005; Sayedyahossein et al., 2012). Ninetysix hours following the first treatments with adenovirus, we
observed significant increases in phospho-SMAD 2 levels in
response to TGF-b1 in Ad-bgal/Ad-bgal and Ad-bgal/Ad-ILK
sequentially transduced cells (Supplementary Figure S2
online). Importantly, the presence of human ILK in cells
sequentially infected with Ad-Cre and Ad-ILK, and
888
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subsequently treated with TGF-b1, restored phospho-SMAD
2 abundance to levels indistinguishable from those observed
in normal cells (Supplementary Figure S2 online).
Modulation of TbRII turnover by ILK

The observed reduction in TbRII levels in ILK-deficient cells
prompted us to determine whether TbRII turnover is altered in
the absence of ILK. To this end, we treated cells with
cycloheximide to inhibit protein synthesis. We then measured
total cellular TbRII levels in lysates prepared at timed intervals
following cycloheximide addition to estimate the apparent
half-life of this receptor (Figure 4a). This experimental design
allowed us to measure not only the abundance of receptors at
the cell surface but also those in intracellular compartments.
Whereas in ILK-expressing cells we calculated an apparent
TbRII half-life of B2.8 hours, in ILK-deficient cells, its half-life
was only about 1.2 hours (Figure 4a). We next examined
whether the levels of ubiquitinated TbRII are increased in ILKdeficient cells, as ubiquitination precedes receptor degradation (Di Guglielmo et al., 2003). Although total TbRII levels in
immunoprecipitates from ILK-deficient cells were lower than
those in normal cells, the relative abundance of ubiquitinated
receptor species was substantially elevated (Figure 4b). Our
data indicate that, in the absence of ILK, TbRII ubiquitination
and degradation are increased. Consistent with this concept,
treatment of ILK-deficient fibroblasts with the proteasome
inhibitor MG132 restored TbRII abundance to levels comparable to those detected in ILK-expressing cells (Figure 4c).
Role of proteasome activity and membrane raft formation on
TGF-b1 receptor signaling in ILK-deficient cells

We next addressed the possibility that attenuated TbR signaling in ILK-deficient fibroblasts was associated with the
increased TbRII degradation in these cells. To this end, we
incubated Ad-Cre or Ad-bgal-transduced fibroblasts with
MG132, to inhibit TbRII proteasomal degradation, and then
measured levels of phospho-SMAD 2 generated in response to
TGF-b1. Phospho-SMAD 2 abundance in MG132-treated ILKdeficient cells was restored to levels indistinguishable from
those in ILK-expressing cells (Figure 5a), indicating that a
major mechanism for the impairment in TbR signaling in these
cells is increased proteasomal TbRII degradation.
TGF-b receptors can be internalized via clathrin-coated pits
and directed to endosomes, promoting sustained signaling and
receptor recycling to the plasma membrane. Alternatively,
they can be internalized via membrane rafts, which direct
them for ubiquitination and subsequent proteasomal and/or
lysosomal degradation (Di Guglielmo et al., 2003; Lonn et al.,
2009). Membrane rafts are specialized cholesterol-containing
plasma membrane microdomains that are disrupted by the
cholesterol-sequestering drug nystatin. Hence, we examined
whether nystatin disruption of membrane raft formation
restored TbRII responses in ILK-deficient fibroblasts. In ILKexpressing cells, phospho-SMAD 2 levels were increased by
TGF-b1 to similar levels in the presence or absence of nystatin
(Figure 5b). Significantly, incubation of ILK-deficient cells with
nystatin restored the formation of phospho-SMAD 2 to levels
indistinguishable from those observed in ILK-expressing cells
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(Figure 5b). These data are consistent with the notion that ILK
modulates the balance between TbRII signaling and degradation pathways and that loss of ILK expression enhances the
TbRII pool directed to membrane rafts and subsequent
degradation.
Interaction between ILK-deficient fibroblasts and squamous
carcinoma cells

Dermal fibroblasts become activated during wound healing
and fibrosis, differentiating into myofibroblasts (Hinz et al.,
2012). In a similar manner, stromal cells neighboring
epithelial carcinomas respond to TGF-b1 and other cytokines secreted by the tumor and become CAFs (reviewed
in Cirri and Chiarugi, 2011). In cutaneous wounds, ILK
expression in dermal fibroblasts is essential for their
differentiation into myofibroblasts in response to TGF-b1 and
mechanical stimulation (Blumbach et al., 2010; Vi et al.,
2011). Accordingly, we reasoned that ILK may also be
involved in the activation of fibroblasts by stimulation with

tumor-derived cytokines. To test this hypothesis, we obtained
conditioned medium from SCC-25 head and neck squamous
carcinoma cells, which secrete TGF-b1, interleukins, and
various other cytokines (Alcolea et al., 2012). We then
cultured ILK-expressing or ILK-deficient cells in the presence
of either serum-free medium, medium containing TGF-b1
(10 ng ml  1), or SCC-25-conditioned medium. The cells
were examined for the formation of a-SMA-containing actin
fibers 24 hours later. In serum-free conditions, there were no
significant differences in the fraction of cells that exhibited
thick a-SMA-containing actin fibers among non-transduced
cells, Ad-bgal- or Ad-Cre-transduced cultures (20–30%;
Figure 6). The presence of TGF-b1 increased the proportion
of non-transduced or Ad-bgal-transduced cells with a-SMApositive fibers to 55 and 42%, respectively, and, these effects
were abrogated in the presence of the TbRI inhibitor
SB431542, demonstrating the specificity of TGF-b1 responses
in this assay. In contrast, treatment with TGF-b1 of ILKdeficient fibroblasts did not increase the fraction of cells
www.jidonline.org
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Figure 5. Inhibition of TbRII degradation and distribution to lipid rafts in ILK-deficient fibroblasts. Primary fibroblasts were infected with Ad-bgal or Ad-Cre.
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TGF-b1; #Po0.05 (analysis of variance). ILK, integrin-linked kinase; TGF-b1, transforming growth factor-b1; TbRII, type II TGF-b receptor.

containing a-SMA fibers (Figure 6). Culture of ILK-expressing
fibroblasts with serum-free SCC-25-conditioned medium
induced a significant increase in the cell population with
a-SMA fibers, albeit slightly less than that observed in the
presence of TGF-b1. Of note, the presence of SB431542 in
SCC-25-conditioned medium prevented the formation of thick
a-SMA actin bundles, indicating the involvement of TGF-b in
this process (Figure 6). In contrast, culture in the SCC-25conditioned medium with or without SB431542 had no effect
on ILK-deficient cells, in which the fraction of a-SMA-positive
fibroblasts remained unchanged (B20%), relative to that
observed with serum-free medium (Figure 6). We conclude
that squamous carcinoma cells secrete factors capable of
activating fibroblasts in a TGF-b- and ILK-dependent manner.
Thus, ILK may also have key roles in the formation of CAFs
promoted by epithelial tumors.
DISCUSSION
Multiple proteins with a variety of functions have now been
shown to associate with ILK both through direct binding and
via intermediate linkers. ILK can also modulate signal transduction events resulting from stimulation of integrins and a
variety of transmembrane receptor Y kinases (Sayedyahossein
et al., 2012; Ho and Dagnino, 2012b; Malan et al., 2013). We
now show that ILK can also associate with a transmembrane
serine/threonine kinase receptor. Our experiments have not
addressed whether ILK binds to TbRII directly or via other
linker protein(s). However, as the association between ILK and
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TbRII is not affected by TGF-b1, these two proteins may be
constitutively associated in dermal fibroblasts.
We have defined a role for ILK in TGF-b signaling in dermal
fibroblasts that appears to involve TbRII stabilization, as
evidenced by the increased turnover of this receptor in
ILK-deficient cells. These observations suggest the possibility
that ILK may modulate TbbRII trafficking, sorting, and/or
degradation. Endocytosis of TbRI/TbRII complexes via clathrin
is necessary for optimal signaling and mediates receptor
recycling to the plasma membrane (Mitchell et al., 2004;
Chen, 2009). In contrast, endocytosis via membrane rafts/
caveolae targets the receptors for degradation. Significantly, in
different cell types and/or contexts, TbRII degradation can be
mediated by the proteasome or the lysosome and can be
uncoupled from TbRI (Noh et al., 2012; Hsu et al., 2013; Zuo
et al., 2013). In primary dermal fibroblasts, a major pathway
for TbRII degradation appears to be through the proteasome.
Steady-state TbR levels are partially determined by the
balance between clathrin- and membrane raft-mediated
endocytosis. Our studies show that, in the absence of ILK,
proteosomal TbRII degradation increases through mechanisms
that involve membrane raft formation. Although we have not
directly assessed the role of ILK in TbRII trafficking, our
observations suggest that ILK may be involved in selectively
targetting TbRII away from endocytic degradatory pathways.
TbRII exhibits both ligand-dependent and constitutive, ligandindependent internalization and recycling (Dore et al., 2001).
In the context of our studies, ILK may not be essential for TbRII
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Figure 6. Effect of SCC conditioned medium on a-SMA expression. (a) Fibroblasts were transduced with Ad-bgal or Ad-Cre or were left untreated. Ninety-six hours
after transduction, the cells were rinsed and incubated for 24 hours in serum-free medium containing BSA, TGF-b1 (10 ng ml  1), TGF-b1 (10 ng ml  1) with
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endocytosis per se, as TGF-b canonical signaling, assessed by
the generation of phospho-SMAD 2, appears to be normal in
ILK-deficient cells when TbR proteasomal degradation is
inhibited. ILK binds the cytoplasmic domain of ADAM12,
A Disintegrin And Metalloprotease family member (Leyme
et al., 2012). ADAM12 is constitutively internalized through
clathrin-dependent mechanisms and directed to recycling
endosomes (Stautz et al., 2012). Significantly, ADAM12 also
binds TbRII, inducing its accumulation in early endosomes

and facilitating SMAD phosphorylation (Atfi et al., 2007). On
this basis, it is tempting to speculate that ILK could
potentially function with ADAM12 to direct TbRII toward
the recycling endosomal pathway. The characteristics of
endocytic uptake and trafficking of TbRII in the absence of
ILK expression and the potential role that ILK has in ADAM12
modulation of TbRII recycling are key issues for future
research. Notably, no significant differences in the
abundance of mRNA encoding SMAD2, SMAD3, and TbRII
www.jidonline.org
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were found in Ad-Cre trasduced, ILK-deficient cells, relative to
Ad-bgal-transduced, ILK-expressing fibroblasts (L Dagnino,
unpublished observations). This is consistent with the
concept that ILK modulates TbRII abundance at the posttranscriptional/post-translational level.
ILK-deficient dermal fibroblasts fail to respond normally to
TGF-b1 and to differentiate into myofibroblasts, both in vivo
and in culture (Blumbach et al., 2010; Vi et al., 2011).
Cultured primary ILK-deficient dermal fibroblasts generated
from 3-week-old mice expressing tamoxifen-inducible Cre
recombinase secrete abnormally low levels of TGF-b but
exhibit SMAD phosphorylation and increased a-SMA expression in responses to exogenous TGF-b1 (Blumbach et al.,
2010). In contrast, we observed that our primary fibroblasts
generated from newborn dermis, in which Ilk gene inactivation is induced by adenovirus-mediated expression of Cre
recombinase, exhibit attenuated responses to this cytokine.
Although the mechanisms involved in these apparently different cell behaviors are unclear, distinct fibroblast populations are present in mouse dermis (Sandulache et al., 2007;
Driskell et al., 2013). Further, we have observed that the
viability of our ILK-deficient cells decreases substantially
5 days after Ad-Cre infection, coincident with a reduction in
ILK protein levels by 490%. In contrast, dermal fibroblasts
directly isolated from tamoxifen-treated ILK-deficient mice
from a different strain have been reported to survive for
several passages (Blumbach et al., 2010). Hence, the heterogeneity in dermal fibroblast populations and experimental
conditions are likely key factors in the different outcomes of
this type of studies, using distinct biological models.
The induction of fibroblast differentiation into myofibroblasts during wound repair requires TGF-b and ILK (Blumbach
et al., 2010; Vi et al., 2011). Similarly, fibroblasts in
the microenvironment surrounding epithelial tumors
resemble wound myofibroblasts and acquire an activated
phenotype characterized by expression of a-SMA and tumor
growth–promoting cytokines (Orimo and Weinberg, 2006).
Squamous carcinomas, such as SCC-25 head and neck
carcinoma cells, express TGF-b1, as well as other cytokines,
and are capable to induce the transition of normal fibroblasts
to CAFs in coculture (Fullar et al., 2012). Our studies now
show that ILK is a required factor for the activation of
fibroblasts and potential transition to a CAF-like phenotype,
in response to factors secreted by squamous carcinoma cells.
Significantly, ILK and TbRII are key mediators of the transition
of fibroblasts to myofibroblast in fibrotic conditions and, based
on our studies, likely have important roles in the generation of
CAFs in response to stimuli from neighboring epithelial
carcinoma cells. Both ILK and TbRII are stabilized by heatshock protein HSP90 (Wrighton et al., 2008; Radovanac et al.,
2013). Thus, under certain conditions, HSP90 inhibitors,
currently in clinical trials for various tumors (Hong et al.,
2013), may be effective anticancer therapeutic tools through
their ability to interfere with two important mediators of CAF
formation, potentially generating a microenvironment less
conducive to support tumor growth.
In summary, we have demonstrated that ILK is necessary for
normal responses to TGF-b1 in primary dermal mouse
892

Journal of Investigative Dermatology (2015), Volume 135

fibroblasts, and for responses of these cells to paracrine
stimuli, necessary for their transition to a CAF-like phenotype,
thus placing ILK at the center of key events in cutaneous
regeneration and tumorigenesis. Disrupting the communication between carcinoma cells and the tumor microenvironment by interfering with ILK activity may be a viable
therapeutic strategy to target epithelial cell carcinomas.
MATERIALS AND METHODS
Cell culture, adenoviral transduction, and transient transfections
All mouse experimentation protocols were approved by the University of Western Ontario Animal Use Subcommittee (Approved
Protocol No. 2007-005, 2011), in accordance with regulations and
guidelines from the Canadian Council on Animal Care. Primary
dermal fibroblast isolation and culture, drug treatments, and adenoviral transduction were conducted as described in Supplementary
Materials and Methods online.

Immunofluorescence and confocal microscopy
Fibroblast cultures were fixed and processed for direct or indirect
immunofluorescence microscopy as described (Nakrieko et al.,
2008c; Ho et al., 2009). For experiments using SCC-25 conditioned
medium, the fraction of a-SMA-positive fibroblasts was determined by
using a color threshold routine on images taken with a  40
objective, and related to the total cell number, determined by
Hoescht 33342. For Adbgal- and Ad-Cre-transduced cells, the
results were determined based on the fraction of a-SMA-positive
cells that were also green fluorescent protein positive. Mean values
were calculated analyzing at least 100 cells per sample. Photomicrographs were obtained with a Leica DMIRBE fluorescence
microscope equipped with an Orca-ER digital camera (Hamamatsu
Photonics, Hamamatsu City, Japan), using Volocity 6.1.1 software
(Improvision-PerkinElmer, Waltham, MA). Confocal images were
captured with a Zeiss LSM5 DuoVarioII scanning laser confocal
microscope, using ZEN 2007 SP1 software (Zeiss, Oberkochen,
Germany). All results shown are representative of three to five
experiments conducted on triplicate samples.
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